Hot Features
Premium
Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 1,256,391 |
|
|||||
| News | - | ||||||
| Day High | 5.04 | Low High |
|||||
| Day Low | 4.70 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| AbSci Corporation | ABSI | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.20 | -4.02% | 4.77 | 15:08:43 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.95 | 4.70 | 5.04 | 4.78 | 4.97 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,569 | 1,256,391 | US$ 4.87 | US$ 6,115,038 | - | 1.1111 - 6.72 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:15:30 | 10 | US$ 4.75 | USD |
AbSci Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 440.53M | 92.94M | - | 5.72M | -110.57M | -1.19 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
AbSci News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABSI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.01 | 6.02 | 4.70 | 5.39 | 1,242,121 | -1.24 | -20.63% |
| 1 Month | 5.30 | 6.72 | 4.70 | 5.62 | 1,395,102 | -0.53 | -10.00% |
| 3 Months | 3.65 | 6.72 | 3.53 | 5.01 | 1,591,425 | 1.12 | 30.68% |
| 6 Months | 1.40 | 6.72 | 1.1111 | 4.25 | 1,252,207 | 3.37 | 240.71% |
| 1 Year | 1.78 | 6.72 | 1.1111 | 3.47 | 900,506 | 2.99 | 167.98% |
| 3 Years | 21.00 | 31.5301 | 1.1111 | 5.16 | 690,381 | -16.23 | -77.29% |
| 5 Years | 21.00 | 31.5301 | 1.1111 | 5.16 | 690,381 | -16.23 | -77.29% |
AbSci Description
| Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. |
